Clinical Trial Update: A Study to Evaluate Efficacy and Safety of BAC in Patient With Alzheimer's Disease or Vascular Dementia [Phase 2]

View source ↗

Summary

Phase 2 study updating efficacy and safety of BAC in Alzheimer's disease or vascular dementia; study completed with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Vascular Dementia

Drugs mentioned

• BAC

Snippet

Sponsor: Charsire Biotechnology Corp. | Conditions: Alzheimer's Disease or Vascular Dementia | Phase 2 | Status: COMPLETED | Results posted: 2021-07-19